Ignite Creation Date:
2025-12-24 @ 2:04 PM
Ignite Modification Date:
2026-02-23 @ 8:08 PM
Study NCT ID:
NCT01887795
Status:
COMPLETED
Last Update Posted:
2016-08-25
First Post:
2013-06-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase Ⅲ Trial of WBRT Versus Erlotinib Concurrent Whole-brain Radiation Therapy as first-line Treatment for Patients With Multiple Brain Metastases From Non-small-cell Lung Cancer(ENTER): a Multicentre, Open-label, Randomised Study
Sponsor:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Yang-1970
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None